Safety, quality & education

From data to quality: the story of Anaesthesia QUAlity (A-QUA), Switzerland's Anaesthesia QUAlity initiative and database

Eur J Anaesthesiol Intensive CarePublished Retrospective observational registry study

Authors' conclusion

A-QUA is a robust, validated programme for national anaesthesia quality monitoring in Switzerland, enabling benchmarking, targeted quality improvement and peri-operative research through continuous, standardised data collection.

Study context

Population
All patients receiving anaesthesia from participating public and private Swiss anaesthesia providers, 2017–2024cases from 54 centres
Participants
2,045,026 patients
Outcome
Hospital and clinic participation, case volume, data completeness, plausibility checks, patient characteristics, anaesthesia techniques, durations, peri-operative events and postoperative care
Methodological detailsnationwide, multicentre registry, routine data
  • Nationwide
  • Multicentre registry
  • Routine data

Main finding

As reported in the abstract

Registry structure, participation and case characteristics · end of 2024
Centres contributing
54
German-speaking region
61%
French-speaking region
35%
Italian-speaking region
4%
Large teaching hospitals
74%
Small and medium-sized teaching hospitals
17%
Nonteaching hospitals
8.8%
Median age, years
56
Women
52%
ASA I to II
66%
GA (including combined)
74%
RA alone
18%
MAC
8.5%
Median anaesthesia duration, min
122
Median surgical duration, min
53

Observational data: associations, not effects.

Further findings

Case studies of the five most frequent procedures

Regional and hospital variation in anaesthesia choice, timing and postoperative destination

Original publication

From data to quality: the story of A-QUA, Switzerland's Anaesthesia QUAlity initiative and database. Eur J Anaesthesiol Intensive Care. Published 2 June 2026. doi:10.1097/ea9.0000000000000112

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.